Re: COVID-19 Coagulopathy: Considerations for UrologistsJ. S. Jue and M. Alameddine J Urol 2020; 204: Epub ahead of print. doi: 10.1097/JU.0000000000001144

Tommaso Cai^{1

2}, Zafer Tandogdu³, Florian M E Wagenlehner⁴, Truls E Bjerklund Johansen^{5

6

7}

Affiliations

¹ Department of Urology Santa Chiara Regional Hospital Trento, Italy.
² Institute of Clinical Medicine, University of Oslo.
³ Northern Institute for Cancer Research, Newcastle University, Newcastle-upon-Tyne, United Kingdom.
⁴ Clinic for Urology, Pediatric Urology and Andrology, Justus-Liebig University Giessen, Giessen, Germany.
⁵ Institute of Clinical Medicine University of Oslo.
⁶ Department of Urology Oslo University Hospital Oslo, Norway.
⁷ Institute of Clinical Medicine, University of Aarhus, Aarhus, Denmark.

Comment

Tommaso Cai et al. J Urol. 2020 Oct.

. 2020 Oct;204(4):848-849.

doi: 10.1097/JU.0000000000001228. Epub 2020 Jul 1.

Tommaso Cai^{1

2}, Zafer Tandogdu³, Florian M E Wagenlehner⁴, Truls E Bjerklund Johansen^{5

6

7}

¹ Department of Urology Santa Chiara Regional Hospital Trento, Italy.
² Institute of Clinical Medicine, University of Oslo.
³ Northern Institute for Cancer Research, Newcastle University, Newcastle-upon-Tyne, United Kingdom.
⁴ Clinic for Urology, Pediatric Urology and Andrology, Justus-Liebig University Giessen, Giessen, Germany.
⁵ Institute of Clinical Medicine University of Oslo.
⁶ Department of Urology Oslo University Hospital Oslo, Norway.
⁷ Institute of Clinical Medicine, University of Aarhus, Aarhus, Denmark.

No abstract available

Comment in

Reply by Authors.
Jue JS, Alameddine M. Jue JS, et al. J Urol. 2020 Oct;204(4):849-850. doi: 10.1097/JU.0000000000001229. Epub 2020 Jul 1. J Urol. 2020. PMID: 32609572 No abstract available.

COVID-19 Coagulopathy: Considerations for Urologists.
Jue JS, Alameddine M. Jue JS, et al. J Urol. 2020 Oct;204(4):640-641. doi: 10.1097/JU.0000000000001144. Epub 2020 May 18. J Urol. 2020. PMID: 32648819 No abstract available.